Physician profile
John C Daly
NPI 1801835905
$1,154.85
in general payments reported to CMS, 2019-2025
8 companies · $93.12 in 2025
The $93.12 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $91.55 · 2022: $238 · 2023: $137 · 2024: $258 · 2025: $93.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $438.19 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $263.49 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $133.01 | 2024 | Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.99 | 2024 | Caplyta |
| Intra-Sana Laboratories | $114.49 | 2023 | Glycate, Reltone 400 Mg, Reltone 200 Mg |
| Otsuka America Pharmaceutical, INC. | $39.04 | 2023-2025 | Rexulti |
| Astellas Pharma US INC | $26.50 | 2019 | |
| Exact Sciences Corporation | $15.14 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Daly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.